{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:58:11Z","timestamp":1778097491835,"version":"3.51.4"},"reference-count":45,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/xtrt2780","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:16:03Z","timestamp":1712272563000},"page":"979-995","source":"Crossref","is-referenced-by-count":6,"title":["Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression"],"prefix":"10.62347","volume":"14","author":[{"given":"Ming-Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition","volume":"11","author":"Thanikachalam","year":"2019","unstructured":"Thanikachalam K and Khan G. Colorectal cancer and nutrition. Nutrients 2019; 11: 164.","journal-title":"Nutrients"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cancers13092073","article-title":"Platinum complexes in colorectal cancer and other solid tumors","volume":"13","author":"K&#xF6","year":"2021","unstructured":"Köberle B and Schoch S. Platinum complexes in colorectal cancer and other solid tumors. Cancers (Basel) 2021; 13: 2073.","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","unstructured":"Meyerhardt JA and Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352: 476-487.","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7: 573-584.","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3747\/co.v18i1.708","article-title":"Oxaliplatin: a review in the era of molecularly targeted therapy","volume":"18","author":"Alcindor","year":"2011","unstructured":"Alcindor T and Beauger N. Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol 2011; 18: 18-25.","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3390\/cancers11101576","article-title":"FOXC1 regulation of miR-31-5p confers oxaliplatin resistance by targeting LATS2 in colorectal cancer","volume":"11","author":"Hsu","year":"2019","unstructured":"Hsu HH, Kuo WW, Shih HN, Cheng SF, Yang CK, Chen MC, Tu CC, Viswanadha VP, Liao PH and Huang CY. FOXC1 regulation of miR-31-5p confers oxaliplatin resistance by targeting LATS2 in colorectal cancer. Cancers (Basel) 2019; 11: 1576.","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.7150\/jca.24474","article-title":"A study on effect of oxaliplatin in microRNA expression in human colon cancer","volume":"9","author":"Evert","year":"2018","unstructured":"Evert J, Pathak S, Sun XF and Zhang H. A study on effect of oxaliplatin in microRNA expression in human colon cancer. J Cancer 2018; 9: 2046-2053.","journal-title":"J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omto.2021.03.010","article-title":"Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2","volume":"21","author":"Sun","year":"2021","unstructured":"Sun W, Ge Y, Cui J, Yu Y and Liu B. Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2. Mol Ther Oncolytics 2021; 21: 87-97.","journal-title":"Mol Ther Oncolytics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ebiom.2019.09.051","article-title":"circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637","volume":"48","author":"Zhang","year":"2019","unstructured":"Zhang Y, Li C, Liu X, Wang Y, Zhao R, Yang Y, Zheng X, Zhang Y and Zhang X. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. EBioMedicine 2019; 48: 277-288.","journal-title":"EBioMedicine"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1002\/jcp.26406","article-title":"Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis","volume":"233","author":"Hsu","year":"2018","unstructured":"Hsu HH, Chen MC, Baskaran R, Lin YM, Day CH, Lin YJ, Tu CC, Vijaya Padma V, Kuo WW and Huang CY. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol 2018; 233: 5458-5467.","journal-title":"J Cell Physiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcb.30394","article-title":"The involvement of Aurora-A and p53 in oxaliplatin-resistant colon cancer cells","volume":"124","author":"Chen","year":"2023","unstructured":"Chen MC, Yang BZ, Kuo WW, Wu SH, Wang TF, Yeh YL, Chen MC and Huang CY. The involvement of Aurora-A and p53 in oxaliplatin-resistant colon cancer cells. J Cell Biochem 2023; 124: 619-632.","journal-title":"J Cell Biochem"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/app11020638","article-title":"The double face of metals: the intriguing case of chromium","volume":"11","author":"Genchi","year":"2021","unstructured":"Genchi G, Lauria G, Catalano A, Carocci A and Sinicropi MS. The double face of metals: the intriguing case of chromium. Applied Sciences 2021; 11: 638.","journal-title":"Applied Sciences"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2019.00024","article-title":"The effect of hexavalent chromium on the incidence and mortality of human cancers: a meta-analysis based on published epidemiological cohort studies","volume":"9","author":"Deng","year":"2019","unstructured":"Deng Y, Wang M, Tian T, Lin S, Xu P, Zhou L, Dai C, Hao Q, Wu Y, Zhai Z, Zhu Y, Zhuang G and Dai Z. The effect of hexavalent chromium on the incidence and mortality of human cancers: a meta-analysis based on published epidemiological cohort studies. Front Oncol 2019; 9: 24.","journal-title":"Front Oncol"},{"key":"ref13","unstructured":"Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ 2004; Suppl: 2-14."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"126606","DOI":"10.1016\/j.jtemb.2020.126606","article-title":"Anti-diabetic properties of genistein-chromium (III) complex in db\/db diabetic mice and its sub-acute toxicity evaluation in normal mice","volume":"62","author":"Li","year":"2020","unstructured":"Li P, Cao Y, Song G, Zhao B, Ma Q, Li Z and He C. Anti-diabetic properties of genistein-chromium (III) complex in db\/db diabetic mice and its sub-acute toxicity evaluation in normal mice. J Trace Elem Med Biol 2020; 62: 126606.","journal-title":"J Trace Elem Med Biol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"126982","DOI":"10.1016\/j.jtemb.2022.126982","article-title":"Hypolipidemic activity and safety evaluation of a rhamnan-type sulfated polysaccharide-chromium (III) complex","volume":"72","author":"Cui","year":"2022","unstructured":"Cui J, Gu X, Wei Z, Qiao L, Chunying D, Wang J, Liu R and Wang P. Hypolipidemic activity and safety evaluation of a rhamnan-type sulfated polysaccharide-chromium (III) complex. J Trace Elem Med Biol 2022; 72: 126982.","journal-title":"J Trace Elem Med Biol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"120991","DOI":"10.1016\/j.biomaterials.2021.120991","article-title":"Cr(V)-Cr(III) in-situ transition promotes ROS generation to achieve efficient cancer therapy","volume":"276","author":"Chen","year":"2021","unstructured":"Chen M, Huang X, Shi H, Lai J, Ma L, Lau TC and Chen T. Cr(V)-Cr(III) in-situ transition promotes ROS generation to achieve efficient cancer therapy. Biomaterials 2021; 276: 120991.","journal-title":"Biomaterials"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jinorgbio.2004.03.018","article-title":"Chromium-containing biomimetic cation triaqua-mu3-oxo-mu-hexapropionatotrichromium (III) inhibits colorectal tumor formation in rats","volume":"98","author":"Pickering","year":"2004","unstructured":"Pickering A, Chang C and Vincent JB. Chromium-containing biomimetic cation triaqua-mu3-oxo-mu-hexapropionatotrichromium (III) inhibits colorectal tumor formation in rats. J Inorg Biochem 2004; 98: 1303-1306.","journal-title":"J Inorg Biochem"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Lin YJ, Sundhar N, Devi HS, Pien HF, Wen SF, Sheu JL, Tsai BC and Huang CY. Development and evaluation of a novel chromium III-based compound for potential inhibition of emerging SARS-CoV-2 variants. Heliyon 2023; 9: e20011.","DOI":"10.1016\/j.heliyon.2023.e20011"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.37796\/2211-8039.1408","article-title":"Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis","volume":"13","author":"Fang","year":"2023","unstructured":"Fang CW, Yang JS, Chiang JH, Shieh PC, Tsai FJ, Tsai CW and Chang WS. Metformin induces autophagy of cisplatin-resistant human gastric cancer cells in addition to apoptosis. Biomedicine (Taipei) 2023; 13: 14-23.","journal-title":"Biomedicine (Taipei)"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Chang WS, Tsai CW, Yang JS, Hsu YM, Shih LC, Chiu HY, Bau DT and Tsai FJ. Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK\/p-38 and suppression of MMP-2\/9. J Food Biochem 2021; 45: e13666.","DOI":"10.1111\/jfbc.13666"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Achudhan D, Li-Yun Chang S, Liu SC, Lin YY, Huang WC, Wu YC, Huang CC, Tsai CH, Ko CY, Kuo YH and Tang CH. Antcin K inhibits VCAM-1-dependent monocyte adhesion in human rheumatoid arthritis synovial fibroblasts. Food Nutr Res 2022; 66.","DOI":"10.29219\/fnr.v66.8645"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.37796\/2211-8039.1394","article-title":"A1 adenosine receptor antagonist induces cell apoptosis in KYSE-30 and YM-1 esophageal cancer cell lines","volume":"13","author":"Zeynali","year":"2023","unstructured":"Zeynali P, Jazi MS, Asadi J and Jafari SM. A1 adenosine receptor antagonist induces cell apoptosis in KYSE-30 and YM-1 esophageal cancer cell lines. Biomedicine (Taipei) 2023; 13: 54-61.","journal-title":"Biomedicine (Taipei)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1097\/HJH.0000000000003285","article-title":"Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway","volume":"40","author":"SY","year":"2022","unstructured":"Lu SY, Hong WZ, Tsai BC, Chang YC, Kuo CH, Mhone TG, Chen RJ, Kuo WW and Huang CY. Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway. J Hypertens 2022; 40: 2502-2512.","journal-title":"J Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/tox.23717","article-title":"Insulin-like growth factor II receptor alpha overexpression in heart aggravates hyperglycemia-induced cardiac inflammation and myocardial necrosis","volume":"38","author":"Lai","year":"2023","unstructured":"Lai CH, Van Thao D, Tsai BC, Hsieh DJ, Chen MY, Kuo WW, Kuo CH, Lu SY, Liao SC, Lin KH and Huang CY. Insulin-like growth factor II receptor alpha overexpression in heart aggravates hyperglycemia-induced cardiac inflammation and myocardial necrosis. Environ Toxicol 2023; 38: 676-684.","journal-title":"Environ Toxicol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12986-020-0432-x","article-title":"Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis","volume":"17","author":"Liu","year":"2020","unstructured":"Liu SP, Shibu MA, Tsai FJ, Hsu YM, Tsai CH, Chung JG, Yang JS, Tang CH, Wang S, Li Q and Huang CY. Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis. Nutr Metab (Lond) 2020; 17: 12.","journal-title":"Nutr Metab (Lond)"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Feng B, Dong TT, Wang LL, Zhou HM, Zhao HC, Dong F and Zheng MH. Colorectal cancer migration and invasion initiated by microRNA-106a. PLoS One 2012; 7: e43452.","DOI":"10.1371\/journal.pone.0043452"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","unstructured":"Satelli A and Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011; 68: 3033-3046.","journal-title":"Cell Mol Life Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","article-title":"E-cadherin in contact inhibition and cancer","volume":"37","author":"AM","year":"2018","unstructured":"Mendonsa AM, Na TY and Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene 2018; 37: 4769-4780.","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, Doench JG, Bennett L and Levine B. Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin. Proc Natl Acad Sci U S A 2021; 118: e2020478118.","DOI":"10.1073\/pnas.2020478118"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1111\/jcmm.16842","article-title":"Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer","volume":"25","author":"Zhang","year":"2021","unstructured":"Zhang B, Chan SH, Liu XQ, Shi YY, Dong ZX, Shao XR, Zheng LY, Mai ZY, Fang TL, Deng LZ, Zhou DS, Chen SN, Li M and Zhang XD. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer. J Cell Mol Med 2021; 25: 8836-8849.","journal-title":"J Cell Mol Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.7150\/ijms.81065","article-title":"Tight junction protein 1 suppresses kidney renal clear cell carcinoma cells proliferation by inducing autophagy","volume":"20","author":"Li","year":"2023","unstructured":"Li M, Zhou DS, Shao XR, Chan SH, Dong ZX, Liu XQ, Chen SN, Qi L, Zarate LV, Wang XM, Du X and Zhang XD. Tight junction protein 1 suppresses kidney renal clear cell carcinoma cells proliferation by inducing autophagy. Int J Med Sci 2023; 20: 1448-1459.","journal-title":"Int J Med Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"784","DOI":"10.14348\/molcells.2021.0130","article-title":"TJP1 contributes to tumor progression through supporting cell-cell aggregation and communicating with tumor microenvironment in leiomyosarcoma","volume":"44","author":"Lee","year":"2021","unstructured":"Lee EY, Kim M, Choi BK, Kim DH, Choi I and You HJ. TJP1 contributes to tumor progression through supporting cell-cell aggregation and communicating with tumor microenvironment in leiomyosarcoma. Mol Cells 2021; 44: 784-794.","journal-title":"Mol Cells"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41598-022-05631-y","article-title":"High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging","volume":"12","author":"Lee","year":"2022","unstructured":"Lee YC, Tsai KW, Liao JB, Kuo WT, Chang YC and Yang YF. High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging. Sci Rep 2022; 12: 1496.","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"7658230","DOI":"10.1155\/2020\/7658230","article-title":"Identification of key genes in gastric cancer by bioinformatics analysis","volume":"2020","author":"Chong","year":"2020","unstructured":"Chong X, Peng R, Sun Y, Zhang L and Zhang Z. Identification of key genes in gastric cancer by bioinformatics analysis. Biomed Res Int 2020; 2020: 7658230.","journal-title":"Biomed Res Int"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Steffens S, Schrader AJ, Vetter G, Eggers H, Blasig H, Becker J, Kuczyk MA and Serth J. Fibronectin 1 protein expression in clear cell renal cell carcinoma. Oncol Lett 2012; 3: 787-790.","DOI":"10.1186\/1471-2490-11-25"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2147\/OTT.S122009","article-title":"Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis","volume":"10","author":"Xia","year":"2017","unstructured":"Xia S, Wang C, Postma EL, Yang Y, Ni X and Zhan W. Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis. Onco Targets Ther 2017; 10: 1743-1755.","journal-title":"Onco Targets Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cellsig.2019.03.008","article-title":"Activation of PERK-eIF2α-ATF4 pathway contributes to diabetic hepatotoxicity: attenuation of ER stress by Morin","volume":"59","author":"Pandey","year":"2019","unstructured":"Pandey VK, Mathur A, Khan MF and Kakkar P. Activation of PERK-eIF2α-ATF4 pathway contributes to diabetic hepatotoxicity: attenuation of ER stress by Morin. Cell Signal 2019; 59: 41-52.","journal-title":"Cell Signal"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1566524016666160523143937","article-title":"The role of the PERK\/eIF2α\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress","volume":"16","author":"Rozpedek","year":"2016","unstructured":"Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA and Majsterek I. The role of the PERK\/eIF2α\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr Mol Med 2016; 16: 533-544.","journal-title":"Curr Mol Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"44674","DOI":"10.1038\/srep44674","article-title":"Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients","volume":"7","author":"Guo","year":"2017","unstructured":"Guo L, Chi Y, Xue J, Ma L, Shao Z and Wu J. Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients. Sci Rep 2017; 7: 44674.","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM and Wallace MB. Colorectal cancer. Lancet 2019; 394: 1467-1480.","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.3945\/jn.117.255901","article-title":"New evidence against chromium as an essential trace element","volume":"147","author":"Vincent","year":"2017","unstructured":"Vincent JB. New evidence against chromium as an essential trace element. J Nutr 2017; 147: 2212-2219.","journal-title":"J Nutr"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm5020017","article-title":"Role of EMT in metastasis and therapy resistance","volume":"5","author":"Smith","year":"2016","unstructured":"Smith BN and Bhowmick NA. Role of EMT in metastasis and therapy resistance. J Clin Med 2016; 5: 17.","journal-title":"J Clin Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1083\/jcb.153.5.1049","article-title":"E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner","volume":"153","author":"CJ","year":"2001","unstructured":"Gottardi CJ, Wong E and Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 2001; 153: 1049-1060.","journal-title":"J Cell Biol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"105572","DOI":"10.1016\/j.biocel.2019.105572","article-title":"Knockdown of IRE1α suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src\/FAK-GTPases signaling","volume":"114","author":"Xie","year":"2019","unstructured":"Xie Y, Liu C, Qin Y, Chen J and Fang J. Knockdown of IRE1α suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src\/FAK-GTPases signaling. Int J Biochem Cell Biol 2019; 114: 105572.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/3\/ajcr0153927.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:52:22Z","timestamp":1766022742000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/3\/ajcr0153927.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/xtrt2780","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}